Targetable mutations are specific genetic alterations in cancer cells that can be directly addressed with targeted therapies. These mutations often drive cancer progression by promoting uncontrolled cell growth, survival, and proliferation. Identifying these mutations enables the development of drugs that specifically inhibit the function of the mutated proteins, offering a more precise and effective treatment compared to traditional chemotherapy.
